India covid-19 India

Colgate Q4FY20 results offer no reason to smile for investors

Reading now: 286
www.livemint.com

Nobody expected the moon from Colgate-Palmolive (India) Ltd’s March quarter results. Expectations were muted to begin with but the oral care products’ company fell short of even the toned down expectations.

The impact of the covid-19 led disruption is evident in the numbers. The company’s revenues declined by 7% year-on-year to ₹1,071 crore.

Note that a Bloomberg poll of analysts had pegged the company’s revenues at ₹1,139 crore. For the March quarter, Colgate’s volumes declined 8% over the same period last year.

According to analysts from JM Financial Institutional Securities Ltd, “Colgate’s higher wholesale dependence (relative to some of the frontline FMCG peers) likely worked against it again during the current disruption, as was the

Read more on livemint.com
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA